Immediate Impact
1 from Science/Nature 60 standout
Citing Papers
Changing etiology and epidemiology of hepatocellular carcinoma: Asia and worldwide
2024 Standout
Adjuvant sintilimab in resected high-risk hepatocellular carcinoma: a randomized, controlled, phase 2 trial
2024 Standout
Works of Xiaoping Chen being referenced
Immunohistochemical Signature Add Prognostic Value in Patients With Early and Intermediate Hepatocellular Carcinoma Underwent Curative Liver Resection
2021
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Xiaoping Chen | 66 | 94 | 58 | 159 | 148 | 43 | 666 | |
| Stephen Parkinson | 20 | 36 | 43 | 62 | 97 | 32 | 808 | |
| Rebecca M. Niemiec | 47 | 92 | 78 | 139 | 133 | 36 | 706 | |
| Steven Gray | 29 | 22 | 32 | 127 | 113 | 31 | 693 | |
| Gregory R. Berry | 11 | 32 | 39 | 130 | 139 | 23 | 800 | |
| Md. Anwarul Islam | 33 | 52 | 22 | 38 | 79 | 79 | 768 | |
| John Hall | 216 | 27 | 44 | 43 | 117 | 46 | 757 | |
| Robert Fish | 16 | 27 | 58 | 173 | 235 | 16 | 819 | |
| Charles H. Smith | 13 | 82 | 37 | 39 | 83 | 94 | 795 | |
| Joseph A. Hamm | 14 | 27 | 76 | 49 | 459 | 53 | 843 | |
| Marietta L. Baba | 18 | 10 | 11 | 144 | 128 | 41 | 718 |
All Works
Login with ORCID to disown or claim papers
Loading papers...